Menarini Group and Radius Health Announce Global License Agree...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
WALTHAM, Mass. and FLORENCE, Italy, July 24, 2020 /PRNewswire-AsiaNet/-- - Menarini licenses global development and commercialization rights of elacestrant, an oral SERD currently in late stage Phase 3 development - Elacestrant further strengthens Menarini's global oncology portfolio, recently bolstered by the acquis...
Authors: LATEST ASIANET NEWS RELEASES